Group Leader Department of Biomedicine, Cancer Metastasis, University of Basel
Nicola Aceto is a Swiss National Science Foundation Professor of Oncology and Group Leader of the Cancer Metastasis laboratory at the University of Basel. Previously, he trained at Harvard Medical School and Massachusetts General Hospital in Boston, at the Broad Institute of MIT and Harvard in Cambridge, and at the Friedrich Miescher Institute in Basel.
He has authored several high-impact publications in leading journals in cancer field, including Cell, Science, Nature Medicine, Nature Methods, among others, and he is an inventor on 4 patents related to the diagnosis and treatment of cancer. His major discovery has been the identification of circulating tumor cell clusters in the blood of patients with cancer, highlighting a previously unappreciated and potentially targetable mechanism of how cancer cells metastasize.
Prof. Aceto is the recipient of several prestigious awards, including an honorable mention within the Wachtel Cancer Research Award from the American Association for the Advancement of Science, an abstract award from Harvard Medical School, an ERC starting grant from the European Union, and a Professorship from the Swiss National Science Foundation. He also serves as scientific advisor for several pharmaceutical companies operating in the oncology field, and he has been an invited speaker in a number of congresses and organizations, including the University of California Berkeley, Google[x] Life Sciences, the Novartis Institute for Biomedical Research, and the World Circulating Tumor Cell Summit.